Charles Conway

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Conway:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Common Shares 0 $148.50 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Charles Conway

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000156218022006950-conway-charles-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 16 -$3,320,757 4 Chief Scientific Officer 03 Oct 2022, 20:23
/report/000156218022000355-conway-charles-2022-01-06 Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 5 -$222,948 4 Chief Scientific Officer 07 Jan 2022, 20:18
/report/000156218021007297-conway-charles-2021-11-23 Biohaven Pharmaceutical Holding Co Ltd. 23 Nov 2021 6 +$393,799 4 Chief Scientific Officer 26 Nov 2021, 15:26
/report/000156218021007296-conway-charles-2017-12-07-restatement Biohaven Pharmaceutical Holding Co Ltd. 07 Dec 2017 1 $0 4/A Chief Scientific Officer 26 Nov 2021, 15:21